Steroid and Growth Factor Regulation of Matrix Metalloproteinase Expression and Endometriosis

Seminars in Reproductive Endocrinology

Volumn 14, Issue 3, 1996, Pages 247-255

  Osteen, Kevin G ^a,c   Bruner, Kaylon L ^a   Sharpe Timms, Kathy L ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Missouri   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; MATRILYSIN; METALLOPROTEINASE; STEROID;

CLASSIFICATION; ENDOMETRIOSIS; ENZYMOLOGY; EXTRACELLULAR MATRIX; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MENSTRUAL CYCLE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ENDOMETRIOSIS; EXTRACELLULAR MATRIX; FEMALE; GROWTH SUBSTANCES; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 7; MENSTRUAL CYCLE; METALLOENDOPEPTIDASES; STEROIDS;

EID: 0030203280     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016334     Document Type: Article

References (75)

1. Cramer DW: Epidemiology of endometriosis in adolescents. In Wilson EA (ed): Endometriosis. New York, Alan Liss, 1987
2. Halme J, Stovall D: Endometriosis and its medical management. In Wallach EE, Zacur HA (eds): Reproductive Medicine and Surgery. St. Louis, Mosby, 1995
3. Franklin RR, Grunert GM: Extragenital endometriosis. In Berger GS (ed): Endometriosis: Advanced Management and Surgical Techniques. New York, Springer-Verlag, 1995
4. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 14:422-469, 1927
5. TeLinde RW, Scott RB: Experimental endometriosis. Am J Obstet Gynecol 60:1147-1173, 1950
6. Ridley JH, Edwards IK: Experimental endometriosis in the human. Am J Obstet Gynecol 76:783-790, 1958
7. Ridley JH: The validity of Sampson's theory of endometriosis. Am J Obstet Gynecol 82:777-782, 1961
8. Lui DTY: Endometriosis: Its association with retrograde menstruation, dysmenorrhea and tubal pathology. Br J Obstet Gynecol 93:859-864, 1986
9. Sorensen SS, Andersen LF, Lose G: Endometriosis by implantation: A complication of endometrial ablation. Lancet 343:1226, 1994
10. Suginami H: A reappraisal of the celomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances. Am J Obstet Gynecol 165:214-218, 1991
11. Fujii S: Secondary mullerian system and endometriosis. Am J Obstet Gynecol 165:219-224, 1991
12. Ishimaru T, Masuzaki H: Peritoneal endometriosis: Endometrial tissue implantation as a primary etiologic mechanism. Am J Obstet Gynecol 165:210-214, 1991
13. Spuijbroek MDEH, Dunselman GAJ, Menheere PPCA, Evers JLH: Early endometriosis invades the extracellular matrix. Fertil Steril 58:929-933, 1992
14. Matrisian LM: The matrix degrading metalloproteinases. Bioessays 14:455, 1992
15. Mauviel A: Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53:288-295, 1993
16. Rodgers WH, Matrisian LM, Giudice LC, et al: Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroids. J Clin Invest 94:946-953, 1994
17. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudia LC, Gorstein F: Expression and localization of matrilysin (Pump-1, MMP-7), a matrix metalloproteinase, in the human endometrium. Am J Obstet Gynecol 168:253-260, 1993
18. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM: Stromal-epithelial interaction mediates steroidal regulation of matrix metalloproteinase expression in the human endometrium. Proc Natl Acad Sci USA 91:10129-10133, 1994
19. Bruner KL, Rodgers WH, Korc M, et al: Transforming growth factor-β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma. Proc Natl Acad Sci 92:7362-7366, 1995
20. Ennis BW, Matrisian LM: Matrix degrading metalloproteinases. J Neurooncol 18:105-109, 1994
21. Basset P, Bellocq JP, Wolf C, et al: A novel, MMP gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990
22. Shapiro SD, Griffen GL, Gilbert DJ, et al: Molecular cloning, chromosomal location and bacteri expression of a novel murine metalloproteinase. J Biol Chem 267:4664-4671, 1992
23. Sato H, Takino T, Okada Cao J, Shinagawa A, Yamamoto E, Seikl M: A matrix metalloproteinase expressed on the surface of invasive tumors. Science 370:61-65, 1994
24. Sharpe-Timms KL, Zimmer RL, Zhang YL, Surewicz K, Penney LL: Partial purification and amino acid sequence analysis of rat and human progesterone-induced uterine protein-1 reveals homology with 72kda gelatinase A. 43rd annual meeting of the Society for Gynecological Investigation, Philadelphia, 1996, Abstract 0-133
25. Uria JA, Ferrando AA, Velasco G, Freije JMP, Lopez-Otin C: Structure and expression in breast tumors of TIMP-3, a new member of the metalloproteinase family. Cancer Res 54:2091-2094, 1994
26. Murphy G, Houbrechts A, Crockett MI, Williamson RA, O'Shea M, Docherty AJP: The n-terminal domain of TIMPs retains MMP inhibitory activity. Biochem 31:10146-10152, 1991
27. Ray JM, Stetler-Stevenson WG: The role of MMPs and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062-2072, 1994
28. Wolf C, Rouyer N, Lutz Y, et al: Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90:1843-1847, 1993
29. Khokha P, Waterhouse P, Yagel S, et al: Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947-950, 1989
30. Salamonsen LA, Nagase H, Suzuki R, Woolley DE: Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A: 72kDa gelatinase) by ovine endometrial cells in vitro: Different regulation and preferential expression by stromal fibroblasts. J Reprod Fertil 98:583-589, 1993
31. Salamonsen LA: Matrix metalloproteinases and endometrial remodeling. Cell Biol Int 18:1139-1144, 1994
32. Schatz F, Papp C, Toth-Pal E, et al: Protease and protease inhibitor expression during in vitro decidualization of human endometrial stromal cells. Ann NY Acad Sci 734:33-42, 1994
33. Schatz F, Papp C, Toth-Pal E, Lockwood C: Ovarian-steroid modulated stromelysin-1 expression in human endometrial stroma and decidual cells. J Clin Endocrinol Metab 78:1467, 1994
34. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA: Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 79:530-536, 1994
35. Martielli M, Campana A, Bischof P: Secretion of matrix metalloproteinases by human endometrial cells in vitro. J Reprod Fertil 98:67-76, 1993
36. Polette M, Nawrocki B, Pintiaux A, et al: Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 71:838-846, 1994
37. Marbiax E, Donnez J, Courtoy P, Eeckou Y: Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial expiants. Proc Natl Acad Sci USA 89:11789-11793, 1992
38. Sharpe KL, Vernon MW: Polypeptide synthesized and released by rat ectopic uterine tissue differ from those of the uterus in culture. Biol Reprod 48:1334-1340, 1993
39. Sharpe KL, Zimmer RL, Griffin WT, Penney LL: Polypeptides synthesized and released by human endometriosis tissue differ from those of the uterine endometrium in culture. Fertil Steril 60:839-851, 1993
40. Sharpe KL, Zimmer RL: Effects of the progesterone antagonist Onapristone (ZK 98.299) on synthesis and secretion of the progesterone uterine protein, PUP-1, in the rat. Annual meeting of the American Fertility Society, Montreal, 1993, Abstract P-271
41. Sharpe KL, Bertero MC, Vernon MW: Detection of a progesterone-induced, secretory protein synthesized by the uteri but not the endometriotic implants of rats with induced endometriosis. Fertil Steril 55:403-410, 1991
42. Anderson TL, Gorstein F, Osteen KG: Stromal-epithelial cell communication, growth factors and tissue regulation. Lab Invest 62:519-521, 1990
43. Osteen KG, Rodgers WH, Hargrove J, Vasquez J, Gorstein F, Matrisian LM: Steroids and growth factors can direct MMP expression in the cycling human endometrium. 41st annual meeting of the Society for Gynecological Investigation, Chicago, 1994, Abstract
44. Bruner KL, Keller NR, Hargrove JT, Matrisian LM, Osteen KG: Endometrial epithelial cells can stimulate the expression of a stromal metalloproteinase. Biol Reprod 50:97, 1994
45. Olive DL: Medical treatment: Alternatives to Danzol. In Schenken RS (ed): Endometriosis: Contemporary Concepts and Clinical Management. JB Lippincott, Philadelphia, 1989
46. Dmowski PW: The role of medical management in the treatment of endometriosis. In Berger GS (ed): Endometriosis: Advanced Management and Surgical Techniques. New York, Springer-Verlag, 1995
47. Bergqvist A, Ferno M: Oestrogen and progesterone receptors in endometriotic tissue and endometrium: Comparison of different cycle phases and ages. Hum Reprod 8:2211-2217, 1993
48. Haining RE, Cameron IT, van Papendorp C, et al: Epidermal growth factor in human endometrium: Proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues. Hum Reprod 6:1200-1205, 1991
49. Simms JS, Chegini N, Williams RS, Rossi AM, Dunn WA: Identification of epidermal growth factor, transforming growth factor-a and epidermal growth factor receptor in surically induced endometriosis in rats. Obstet Gynecol 78:850-857, 1991
50. Isaacson KB, Galman M, Coutifaris C, Little CR: Endometrial synthesis and complement component-C3 by patients with and without endometriosis. Fertil Steril 53:836-841, 1990
51. Ami Y, Suzaki Y, Goto N: Endometriosis in Cynomolgus monkeys retired from breeding. J Vet Med Sci 55:7-11, 1993
52. Cramer DW, Wilson E, Stillman RJ, et al: The relationship of endometriosis to menstrual characteristics, smoking and exercise. JAMA 205:1904-1908, 1986
53. Walters MD: Definitive surgery. In Schenken RS (ed): Endometriosis: Contemporary Concepts and Clinical Management. Philadelphia, JB Lippincott, 1989
54. Ramzy I: Pathology. In Schenken RS (ed): Endometriosis: Contemporary Concepts and Clinical Management. Philadelphia, JB Lippincott, 1989
55. Lessey BA, Metzger DA, Haney AF, McCarty KS Jr: Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: Comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 49:229-235, 1989
56. Melega C, Balducci M, Buletti C, Galassi A, Jasonni V, Flamigni C: Tissue factors influencing growth and maintenance of endometriosis. NY Acad Sci 622:256-265, 1991
57. Saito T, Mizumoto H, Kuroki K, Fujii M, Mori S, Kudo R: Expression of MMP-3 and TIMP-I in the endometriosis and the influence of Danazol. Acta Obstet Gynaecol Jpn 47:495-496, 1995
58. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, et al: Coupling of dual signal pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci 89:4658-4662, 1991
59. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLaclan JA: Peptide growth factors elicit estrogen receptor-dependent treanscriptional activation of an estrogen-responsive element. Molec Endrocrinol 7:992-998, 1993
60. Nelson KG, Takahashi T, Bessert NL, Walmer DK, McLachlan JA: EGF replaces estrogen in the stimulation of female genital tract growth and differentiation. Proc Natl Acad Sci USA 88:21-25, 1991
61. Mellor SJ, Thomas EJ: The action of estradiol and EGF in endometrial and endometriotic stroma in vitro. Fertil Steril 62:507-513, 1994
62. Taketani Y, Mizuno M: Hormonal regulation of the cell growth in an endometriotic cell culture system. Arch Gynecol Obstet 251:29-34, 1992
63. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI: Immunohistochemical localization of TGF-βl, TGF-β2, and TGF-β3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105, 1991
64. Kauma S, Matt D, Stephen S, Eierman D, Turner T: IL-Ib, human leukocyte antigen HLA-Dra and TGF-β expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 163:1430-143, 1990
65. Chegini N, Gold LI, Williams S: Localization of TGF-β isoforms TGF-βl, TGF-β2 and TGF-β3 in surgically induced endometriosis in the rat. Obstet Gynecol 83:455-461, 1994
66. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR: TGF-β activity is increased in the peritoneal fluid of women with endometriosis. Obstet Gynecol 83:287-292, 1994
67. Osteen KG, Bruner KL, Gold LI, Hargrove JT: Steroidal regulation of TGF-β expression in normal human endometrium and endometriosis. Annual meeting of the American Fertility Society, Montreal, 1993, Abstract
68. Moses HL: TGF-β regulation of epithelial cell proliferation. Molec Reprod Dev 32:179-184, 1992
69. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DS, Sporn MB: Type βtransforming growth factor: A bifunctional regulator of cell growth. Proc Natl Acad Sci USA 82:119-123, 1985
70. Theodorescu D, Sheehan C, Kerbel RS: TGF-β gene expression depends on tissue architecture. In Vitro Cell Dev Biol 29A:105-108, 1993
71. Osteen KG, Bruner KL, Keller NR, Hargrove JT, Meiner MH: Suppression of a stromal metalloproteinase by TGF-β requires the presence of epithelial cells. Biol Reprod 52:161, 1995
72. Sharpe-Timms KL, Penney LL, Zimmer RL, Wright JA, Zhang Y, Surewicz KS: Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-I (TIMP-I). J Clin Endocrinol Metab 80:3784-3787, 1995
73. Hampton AL, Salamonsen LA: Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 141:R1-R3, 1994
74. Keisler L, Keisler DH, Mclntush EW, et al: Tissue inhibitor of metalloproteinase-1 (TIMP-I) concentrations are reduced in peritoneal fluid of women with pelvic endometriosis, pain or infertility. 43rd annual meeting of the Society for Gynecological Investigation, Philadelphia, 1996, Abstract P-270
75. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG: Progesterone suppression of matrix metalloproteinases prevents establishment of endometriotic-like human lesions in nude mice. J Clin Invest 1996 (submitted for publication)